Dare Bioscience, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Dare Bioscience, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Dare Bioscience, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.45M, a 424% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.45M +$1.17M +424% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.56M +$1.19M +324% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.32M +$862K +188% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $182K -$364K -66.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $276K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $368K Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $458K Dec 31, 2022 10-K 2024-03-28
Q3 2022 $546K Sep 30, 2022 10-Q 2022-11-10
Q3 2019 $173K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $193K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $213K Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $232K Jan 1, 2019 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.